Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders
Open accessThe DOI matches its Crossref record; 87 of the 91 references it cites were found in a registry or an index; 17 of the 43 sources its claims cite were checked for support.
Abstract
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders with a complex inheritance pattern. While many rare variants in synaptic proteins have been identified in patients with ASD, little is known about their effects at the synapse and their interactions with other genetic variations. Here, following the discovery of two de novo SHANK2 deletions by the Autism Genome Project, we identified a novel 421 kb de novo SHANK2 deletion in a patient with autism. We then sequenced SHANK2 in 455 patients with ASD and 431 controls and integrated these results with those reported by Berkel et al. 2010 (n = 396 patients and n = 659 controls). We observed a significant enrichment of variants affecting conserved amino acids in 29 of 851 (3.4%) patients and in 16 of 1,090 (1.5%) controls (P = 0.004, OR = 2.37, 95% CI = 1.23-4.70). In neuronal cell cultures, the variants identified in patients were associated with a reduced synaptic density at dendrites compared to the variants only detected in controls (P = 0.0013). Interestingly, the three patients with de novo SHANK2 deletions also carried inherited CNVs at 15q11-q13 previously associated with neuropsychiatric disorders. In two cases, the nicotinic receptor CHRNA7 was duplicated and in one case the synaptic translation repressor CYFIP1 was deleted. These results strengthen the role of synaptic gene dysfunction in ASD but also highlight the presence of putative modifier genes, which is in keeping with the "multiple hit model" for ASD. A better knowledge of these genetic interactions will be necessary to understand the complex inheritance pattern of ASD.
Overview
CoChat Summary
TL;DR
This study identifies a novel de novo SHANK2 deletion and finds enrichment of conserved SHANK2 variants in ASD, with patient variants reducing synaptic density in vitro. It also reports inherited 15q11–q13 CNVs in all three patients with de novo SHANK2 deletions, supporting a multiple-hit model.
Key findings
- A novel 421.2 kb de novo SHANK2 deletion was found in patient AU038_3 with autism and moderate ID; it covered 12 exons (E5–E16), altered all SHANK2 isoforms, was absent from parents, originated on the maternal chromosome, and was absent in more than 5000 controls and the Database of Genomic Variants.
- SHANK2 variants affecting conserved amino acids were enriched in ASD: 29 of 851 (3.4%) patients versus 16 of 1090 (1.5%) controls (Fisher’s exact test 1-sided, P = 0.004, OR = 2.37, 95% CI = 1.23–4.70).
- In cultured neurons, 8 variants reduced Shank2-positive synapse density; after Bonferroni correction, 4 remained significant (A729T, G1170R, L1722P identified only in patients; S557N observed more frequently in patients). Patient variants were associated with lower synaptic density than variants shared by patients and controls (P = 0.022) or detected only in controls (P = 0.0013).
- All three patients with de novo SHANK2 deletions also carried inherited 15q11–q13 CNVs: two had a 496 kb CHRNA7 duplication, and one had a 468 kb BP1–BP2 deletion removing NIPA1, NIPA2, CYFIP1, and TUBGCP5.
Methods
- CNV analysis used Illumina 1M Duo SNP arrays in 260 patients with ASD; mutation screening sequenced SHANK2E in 230 patients and 230 controls and ProSAP1A in an additional 225 patients and 201 controls, integrated with Berkel et al. 2010 (396 patients and 659 controls); enrichment was tested with 1-sided Fisher’s exact tests.
- Functional assays introduced 16 variants from the first screen into rat GFP-ProSAP1A/Shank2A cDNA, transfected primary rat hippocampal neurons, and quantified Shank2-positive synapses per 10 µm dendrite using Mann-Whitney U tests and Student’s t tests.
- CNV burden was analyzed in the three patients with de novo SHANK2 deletions and in the control carrying the SHANK2 splice mutation, using the study’s 260 patients/290 controls and the Autism Genome Project dataset of 996 patients/1287 controls, with 2-sided Fisher’s exact tests.
Limitations
- The paper states that the in vitro assays show variants can potentially impact protein function but do not confirm deleterious effects on neuronal function in vivo in people carrying them; parents were apparently asymptomatic, so the causative role of inherited variants remains difficult to ascertain.
- The paper states that the epistasis findings are based on small numbers and that, from a single control subject, it cannot formally prove that additional hits at SNTG2 and/or MYT1L acted as suppressor mutations.
- Evident from the text: the functional work relies on overexpression in cultured neurons rather than endogenous or in vivo models, and several co-occurring CNV comparisons were not statistically significant (e.g., CHRNA7 duplication P = 0.19; ARHGAP11B deletion P = 0.15; BP1–BP2 deletion P = 0.74), so the multiple-hit interpretation rests on small patient counts.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 SHANK2 mutations in patients with ASD. A. A heterozygous deletion of SHANK2 was identified with the Illumina Human 1M-Duo SNP array in a patient with autism (AU038_3). The deletion spans 421 kb on chromosome 11q13.3, covers twelve exons of the human SHANK2 and is not present in the parents. Each dot shows Log R Ratio (LRR; in red) and B allele frequency (BAF; in green). QuantiSNP score is represented with a blue line and indicates the deletion size. B. Location of the CNV and sequence variants (from this study and Berkel et al. 2010) along the SHANK2 protein: in red the variations specific to ASD, in orange the variations shared by ASD and controls and in green the variations specific to controls [26]. The breakpoints of the SHANK2 deletion in AU038_3 are represented with a dotted line on the protein. Stars indicate the variants affecting conserved amino acids. C. A total of 40 variants were identified and variants affecting conserved amino acids in other SHANK proteins are enriched in patients with ASD (nconserved = 12 and nnon-conserved = 3) compared with controls (nconserved = 6 and nnon-conserved = 11) (Fisher's exact test 1-sided, P = 0.013, OR = 6.83, 95% IC = 1.19–53.40). D. The percentage of carriers of SHANK2 variants in patients with ASD and Controls. Variants affecting a conserved amino acid among the SHANK proteins are enriched in patients with ASD (nconserved = 29 and nnon-conserved = 822) compared with controls (nconserved = 16 and nnon-conserved = 1074) (Fisher's exact test 1-sided, P = 0.004, OR = 2.37, 95% CI = 1.23–4.70). Open squares and filled squares represent the non-conserved and conserved amino acids, respectively. ANK, Ankyrin repeat domain; SH3, Src homology 3 domain; PDZ, postsynaptic density 95/Discs large/zona occludens-1 homology domain; SAM, sterile alpha motif domain; BSR, brain specific region; H, homer binding site; D, dynamin binding site; C, cortactin binding site. The proline-rich region is represented as a horizontal gray line.](https://figures.cochat.ai/paper-figures/40c3509135944673ade3b033d2ba4823/genetic-and-functional-analyses-of-shank2-mutations-suggest-a-multiple-hit-model-figure-2.jpg)



![Figure 6 Inherited 15q11–q13 CNVs identified in three ASD patients carrier of a de novo SHANK2 deletion. Deletions (del) and duplications (dup) are indicated in red and blue, respectively. Paternally and maternally imprinted genes are indicated in yellow and pink, respectively. Genes altered by the CNVs are indicated in blue or red. The bottom part of the figure indicates the location of the deletions/duplications previously associated with neuropsychiatric disorders [43]–[61]. BP, breakpoint; Inh_M, inherited by mother; Inh_F, inherited by father; AS, Angelman syndrome; ASD, Autism spectrum disorders; ADHD, attention deficit-hyperactivity disorder; BP, bipolar disorder; DD: developmental delay; DBD, disruptive behavior disorder; EPI, epilepsy; GAD, generalized anxiety disorder; OCD, obsessive-compulsive disorder; ID, intellectual disability; PWS, Prader-Willi syndrome; SCZ, schizophrenia.](https://figures.cochat.ai/paper-figures/3674224577a34df0a318dfdf8464e2e8/genetic-and-functional-analyses-of-shank2-mutations-suggest-a-multiple-hit-model-figure-6.jpg)
Verification
Claims the paper makes
7 Valid · 2 Not valid · 17 Not checked · 98 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“These duplications are considered of uncertain clinical significance since they were previously detected at similar frequencies in patients with epilepsy (6 of 647, 0.93%), in controls (19 of 3699, 0.51%) [50], and in subjects referred for chromosomal microarray analysis (55 of 8832, 0.62%) [51].”
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Results > Additional CNVs affect neuronal genes in patients with de novo SHANK2 deletions and in the control carrying the SHANK2 splice mutation
What the sources say
- Partly supportedcites [50] Helbig I Mefford HC Sharp AJ Guipponi M Fichera M 2009 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 41 160 162 19136953 PMC3026630 sourceExperimental — accuracy not yet measured
The passage on CHRNA7 duplications (section labeled Abstract; no page given) reports similar frequencies in epilepsy cases and controls (P = 0.27) and concludes that the duplication is not a major risk factor for idiopathic generalized epilepsy. It reports 12 of 1,223 cases and 23 of 3,699 controls, however, not the 6 of 647 and 19 of 3,699 attributed to this source. The chromosomal-microarray referral figure is attached to a different citation in the citing sentence. (LLM, conf=0.88)
- Supportedcites [51] Szafranski P Schaaf CP Person RE Gibson IB Xia Z 2010 Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 31 840 850 20506139 PMC3162316 source
The Subjects and Methods section reports 55 small CHRNA7 microduplications among 8,832 people referred for chromosomal microarray analysis, matching the figure attached to this citation. The abstract calls their clinical significance uncertain, and the Discussion says the limited control frequency data were not significantly different from those in patients. The epilepsy and control counts in the citing sentence are attached to a different citation. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“As reported for SHANK3 [7], no other coding variations were detected in the remaining SHANK2 allele of the deletion carriers”
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Discussion > Deleterious SHANK2 variations are enriched in patients with ASD, but also observed in controls
What the sources say
- Could not verifycites [7] Durand CM Betancur C Boeckers TM Bockmann J Chaste P 2007 Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39 25 27 17173049 PMC2082049 sourceExperimental — accuracy not yet measured
Our copy of Durand et al. (2007) describes the deletion carriers (family ASD 1 proband with a de novo 22q13 deletion breaking in SHANK3 intron 8, Results p. 2 and Fig. 1 legend p. 6; family ASD 3 girl with a 22qter deletion, Results p. 3) and reports rare nonsynonymous SHANK3 variations only in 'the remaining individuals with ASD' (Results p. 3), but no passage states that the retained (non-deleted) SHANK3 allele of the deletion carriers was sequenced and found free of coding variations. The nearest sentence, 'No other SHANK3 deletions or duplications were observed after screening 155 individuals by quantitative PCR' (Results p. 3), concerns copy-number changes across the cohort, not coding variants on the remaining allele. Searches on 'remaining/second/wild-type allele', 'hemizygous deletion carriers', and 'coding variations in deletion patients' returned no passage addressing the attributed point, so the parallel the citing authors draw cannot be checked against this paper. (LLM, conf=0.70)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Notably, the three ASD patients with de novo SHANK2 deletions also carried CNVs on chromosome 15q11–q13, a region associated with ASD [43], [47], [48], [50]–[52], [72].”
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Discussion > Additional CNVs in subjects with SHANK2 mutations may modulate the risk for ASD
What the sources say
- Supportedcites [43] Miller DT Shen Y Weiss LA Korn J Anselm I 2009 Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 46 242 248 18805830 PMC4090085 source
The Introduction (page unavailable) states that genomic imbalance in proximal chromosome 15q, including duplications at 15q11–q13, has been associated with autism. This supports the regional association for which this citation is offered; the sentence’s identification of three patients with SHANK2 deletions is not attributed specifically to this source. (LLM, conf=0.90)
- Could not verifycites [47] Sharp AJ Mefford HC Li K Baker C Skinner C 2008 A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat Genet 40 322 328 18278044 PMC2365467 sourceExperimental — accuracy not yet measured
The paper’s Abstract describes 15q13.3 deletions in patients with intellectual disability and seizures, not the three ASD patients with de novo SHANK2 deletions. Searches for ASD, autism, and 15q11–q13 did not find a passage in our copy establishing the claimed ASD association or those patients’ additional CNVs. (LLM, conf=0.76)
- Not checked yetcites [48] Masurel-Paulet A Andrieux J Callier P Cuisset JM Le Caignec C 2010 Delineation of 15q13.3 microdeletions. Clin Genet 78 149 161 20236110 source
plainstates an associationn = 3- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the most compelling candidate in the deleted region is CYFIP1 [45], [53], which codes for a binding partner of FMRP, the protein responsible for fragile X syndrome.”
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Discussion > Additional CNVs in subjects with SHANK2 mutations may modulate the risk for ASD
What the sources say
- Partly supportedcites [45] van der Zwaag B Staal WG Hochstenbach R Poot M Spierenburg HA 2010 A co-segregating microduplication of chromosome 15q11.2 pinpoints two risk genes for autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet 153B 960 966 20029941 PMC2933514 sourceExperimental — accuracy not yet measured
The paper identifies CYFIP1 as the best candidate gene in the 15q11.2 region and says it directly interacts with FMRP (passages labeled Abstract; page unavailable). Its own ASD findings concern a duplication, not a deletion, so it does not establish CYFIP1 as the leading candidate specifically for the citing sentence’s deleted region. (LLM, conf=0.84)
- Supportedcites [53] Stefansson H Rujescu D Cichon S Pietilainen OP Ingason A 2008 Large recurrent microdeletions associated with schizophrenia. Nature 455 232 236 18668039 PMC2687075 source
The Abstract passage on the 15q11.2 deletion (passages 8 and 1) identifies CYFIP1 as the gene most likely to explain the associated phenotype. It says CYFIP1 interacts with FMRP and that fragile X syndrome is caused by loss of FMRP function. (LLM, conf=0.93)
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the patient sample, 5/5 variants affected conserved amino acids in the SHANK proteins compared with only 2/6 in the group of variants identified in patients and controls, and 2/5 in the control group.”
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Results > Several SHANK2 variants identified in patients alter synapse density in cultured neurons
plainstates an associationn = 5- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
61 more claims
Create a free account to see all 124 claims and to verify the 26 references still open.
- It may state two separate claims as one. 34
- Probably not a substantial claim. 35
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SHANK genes display a complex transcriptional regulation with multiple intragenic promoters and extensive alternatively spliced exons both in humans and mice (Leblond et al., 2012; Lim et al., 1999; Maunakea et al., 2010; McWilliams et al., 2004; Redecker et al., 2006; Wang et al., 2011; Wilson et al., 2003).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Leblond et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent evidence indicates that dysregulation and or mutations of FMRP-interacting proteins, such as the cytoplasmic FMRP-interacting protein 1 (CYFIP1) (52-55), eukaryotic initiation factor 4 (eIF4E) (56,57), and a subset of FMRP mRNA targets (58), may contribute to the ASD phenotype observed in FXS.”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [55]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Deletions and duplications of a chromosomal region including CYFIP1 have been linked to ID, ASD, and schizophrenia (Cooper et al., 2011, Doornbos et al., 2009, Leblond et al., 2012, Murthy et al., 2007, Nowicki et al., 2007, Tam et al., 2010, van der Zwaag et al., 2010, von der Lippe et al., 2010, Zhao et al., 2012).”
From CYFIP1 Coordinates mRNA Translation and Cytoskeleton Remodeling to Ensure Proper Dendritic Spine Formation (2013) · cites this paper as Leblond et al., 2012
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SHANK2 exhibits transcriptional regulation similar to SHANK3 (Leblond et al., 2012).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Leblond et al., 2012
The cited source says what the claim attributes to it.
In the citing paper
“However, a recent report indicates that SHANK2E is also expressed in brain tissues in humans (Leblond et al., 2012).”
From Modeling Autism by SHANK Gene Mutations in Mice (2013) · cites this paper as Leblond et al., 2012
8 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Results > SHANK2 coding variants affecting conserved amino acids are enriched in patients with ASD
“The two close duplications span 264 kb and 245 kb on chromosome 2 and altered LOC339822 and SNTG2, and PXDN and MYT1L, respectively.”
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Results > Additional CNVs affect neuronal genes in patients with de novo SHANK2 deletions and in the control carrying the SHANK2 splice mutation
“Two close duplications on 2p25.3 were detected, altering four genes, LOC391343, SNTG2, PXDN and MYT1L.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Results > SHANK2 isoforms are differentially expressed in human tissues
“Finally, the shortest isoform (AF141901), also originally described in the rat”
§ Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders > Results > SHANK2 coding variants affecting conserved amino acids are enriched in patients with ASD
“except for the AF1411901 isoform, where it altered the protein sequence (G263V).”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194 · cited 2×
“All variants were evaluated for potential pathogenicity using the HumDIV method for rare alleles of PolyPhen2 [41].”
A map of human genome variation from population-scale sequencing.
The 1000 Genomes Project Consortium (2010) · Nature · doi:10.1038/nature09534 · Cited by 7,877 · cited 2×
“Initial results from the 1000 genomes project has estimated that, on average, each person carries approximately 250 to 300 loss-of-function variants in annotated genes and 50 to 100 variants previously implicated in inherited disorders [71].”
A psychobiological model of temperament and character
Cloninger, C. R. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820240059008 · Cited by 5,458 · cited 4×
“Regarding personality traits, none of her scores for TCI items were different from those found in the general population.”
InfluentialDirect conversion of fibroblasts to functional neurons by defined factors
Vierbuchen, T., Ostermeier, A., Pang, Z. P., Kokubu, Y., Südhof, T. C., & Wernig, M. (2010) · Nature · doi:10.1038/nature08797 · Cited by 3,017 · cited 1×
“embryonic and postnatal fibroblasts into functional neurons [68].”
Functional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 7×
“The 6319_3 and 5237_3 patients were described by the AGP [9].”
InfluentialSelf-citationGenetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970 · cited 1×
“Previously, twin and family studies have conclusively described ASD as the most ‘‘genetic’’ of neuropsychiatric disorders, with concordance rates of 82–92% in monozygotic twins versus 1–10% in dizygotic twins [3], but a recent study finds evidence for a more substantial environmental component [4].”
Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism
Study, P. A. R. I. S., Jamain, S., Quach, H., Betancur, C., Råstam, M., Colineaux, C., Gillberg, I. C., Soderstrom, H., Giros, B., Leboyer, M., et al. (2003) · Nature Genetics · doi:10.1038/ng1136 · Cited by 1,851 · cited 6×
“ABCC6, ATP-binding cassette, sub-family C, member 6 pseudogene 2; ADAM, ADAM metallopeptidase; AMY1, amylase (salivary); AMY2A, amylase (pancreatic); ARHGAP11B, Rho GTPase activating protein 11B; CAMSAP1L1, calmodulin regulated spectrin-associated protein 1-like 1; CHRNA7, cholinergic receptor, nicotinic, alpha 7; CNT…”
InfluentialSelf-citationNeuroligins and neurexins link synaptic function to cognitive disease
Südhof, T. C. (2008) · Nature · doi:10.1038/nature07456 · Cited by 1,849 · cited 1×
“These proteins play a crucial role in the formation and stabilization of synapses [21], as well as in synaptic homeostasis [22].”
Structural Variation of Chromosomes in Autism Spectrum Disorder
Marshall, C. R., Noor, A., Vincent, J. B., Lionel, A. C., Feuk, L., Skaug, J., Shago, M., Moessner, R., Pinto, D., Ren, Y., et al. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.12.009 · Cited by 1,815 · cited 1×
“Remarkably, all three patients with SHANK2 de novo deletions also carried rare inherited genetic imbalances at chromosome 15q11– q13 (Figure 6), a region associated with Angelman syndrome, Prader-Willi syndrome and other neuropsychiatric disorders, including ASD [42–61].”
Self-citationWang, K., Li, M., Hadley, D., Liu, R., Glessner, J., Grant, S. F. A., Hakonarson, H., & Bucan, M. (2007) · Genome Research · doi:10.1101/gr.6861907 · Cited by 1,792 · cited 3×
“When the QC criteria were met, we used two CNV calling algorithms, QuantiSNP [86] and PennCNV [87], and the CNV viewer, SnipPeep (http://snippeep.”
Large recurrent microdeletions associated with schizophrenia.
GROUP, Stefansson, H., Rujescu, D., Cichon, S., Pietiläinen, O. P. H., Ingason, A., Steinberg, S., Fossdal, R., Sigurdsson, E., Sigmundsson, T., et al. (2008) · Nature · doi:10.1038/nature07229 · Cited by 1,745 · cited 5×
“400 kb) performed on 15,767 children with ID and various congenital defects, and 8,329 unaffected adult controls [20], deletions affecting CYFIP1 , NIPA1 , NIPA2 and TUBGCP5 were associated with neurodevelopmental disorder (P= 4.73 6 10 2 6 ), epilepsy (P= 1.48 6 10 2 3 ) and autism (P= 1.99 6 10 2 2 ).”
InfluentialSelf-citationDurand, C. M., Betancur, C., Boeckers, T. M., Bockmann, J., Chaste, P., Fauchereau, F., Nygren, G., Rastam, M., Gillberg, I. C., Anckarsäter, H., et al. (2007) · Nature Genetics · doi:10.1038/ng1933 · Cited by 1,602 · cited 9×
“Such brain specific splicing has been already observed for exon 18 in SHANK3 [7], which is similar to exon 19 and 20 in SHANK2.”
InfluentialSelf-citationRare chromosomal deletions and duplications increase risk of schizophrenia
The International Schizophrenia Consortium (2008) · Nature · doi:10.1038/nature07239 · Cited by 1,475
Mapping autism risk loci using genetic linkage and chromosomal rearrangements
The Autism Genome Project Consortium (2007) · Nature Genetics · doi:10.1038/ng1985 · Cited by 1,402 · cited 1×
“Mutations of genes coding for synaptic cell adhesion molecules and scaffolding proteins, such as neuroligins (NLGN), neurexins (NRXN) and SHANK, have been recurrently reported in patients with ASD [7–10, 13, 14 ,20].”
A copy number variation morbidity map of developmental delay
Cooper, G. M., Coe, B. P., Girirajan, S., Rosenfeld, J. A., Vu, T. H., Baker, C., Williams, C., Stalker, H., Hamid, R., Hannig, V., et al. (2011) · Nature Genetics · doi:10.1038/ng.909 · Cited by 1,351 · cited 4×
“400 kb) performed on 15,767 children with ID and various congenital defects, and 8,329 unaffected adult controls [20], deletions affecting CYFIP1, NIPA1, NIPA2 and TUBGCP5 were associated with neurodevelopmental disorder (P = 4.”
InfluentialSanders, S. J., Ercan-Sencicek, A. G., Hus, V., Luo, R., Murtha, M. T., Moreno-De-Luca, D., Chu, S. H., Moreau, M. P., Gupta, A. R., Thomson, S. A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.002 · Cited by 1,263 · cited 2×
“However, the occurrence of two or more deleterious copy number variants (CNV) or mutations in a subset of patients also suggested that independent loci could act in concert to induce the development of ASD [9,13–16].”
Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations
O'Roak, B. J., Deriziotis, P., Lee, C., Vives, L., Schwartz, J. J., Girirajan, S., Karakoc, E., MacKenzie, A. P., Ng, S. B., Baker, C., et al. (2011) · Nature Genetics · doi:10.1038/ng.835 · Cited by 1,203 · cited 1×
“It was supported by the identification of apparently monogenic forms of ASD, each affecting a limited number of patients (1–2% for the most replicated genes) [7–14].”
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979 · cited 1×
“A similar suppressor effect has been demonstrated by the decrease of abnormal behavior of the Fmr1 mutant mice carrying a heterozygous mutation of the metabotropic glutamate receptor mGluR5 [84].”
Betancur, C. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.078 · Cited by 954 · cited 1×
“The genetic causes of ASD are diverse [18], but the main category of genes associated with the disorder is related to the development and function of neuronal circuits [6,19].”
Self-citationA de novo paradigm for mental retardation.
Vissers, L. E. L. M., de Ligt, J., Gilissen, C., Janssen, I., Steehouwer, M., de Vries, P., van Lier, B., Arts, P., Wieskamp, N., del Rosario, M., et al. (2010) · Nature Genetics · doi:10.1038/ng.712 · Cited by 852 · cited 1×
“Therefore, as previously observed for ID [85], our results suggest that the cooccurrence of de novo mutations, together with inherited variations might play a role in the genetic susceptibility to ASD.”
Rare de novo and transmitted copy-number variation in autistic spectrum disorders
Levy, D., Ronemus, M., Yamrom, B., Lee, Y.-H., Leotta, A., Kendall, J., Marks, S., Lakshmi, B., Pai, D., Ye, K., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.015 · Cited by 712 · cited 2×
“Mutations of genes coding for synaptic cell adhesion molecules and scaffolding proteins, such as neuroligins (NLGN), neurexins (NRXN) and SHANK, have been recurrently reported in patients with ASD [7–10, 13, 14 ,20].”
Gilman, S. R., Iossifov, I., Levy, D., Ronemus, M., Wigler, M., & Vitkup, D. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.021 · Cited by 701 · cited 1×
“The genetic causes of ASD are diverse [18], but the main category of genes associated with the disorder is related to the development and function of neuronal circuits [6,19].”
Contribution of SHANK3 Mutations to Autism Spectrum Disorder
Moessner, R., Marshall, C. R., Sutcliffe, J. S., Skaug, J., Pinto, D., Vincent, J., Zwaigenbaum, L., Fernandez, B., Roberts, W., Szatmari, P., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/522590 · Cited by 681 · cited 1×
“Deletions of ProSAP2/SHANK3 at chromosome 22q13 are one of the major genetic abnormalities in neurodevelopmental disorders [20], and mutations of ProSAP2/ SHANK3 have been identified in patients with ASD, intellectual disability (ID) and schizophrenia [7,23–25].”
Self-citationA recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay
Girirajan, S., Rosenfeld, J. A., Cooper, G. M., Antonacci, F., Siswara, P., Itsara, A., Vives, L., Walsh, T., McCarthy, S. E., Baker, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.534 · Cited by 667 · cited 1×
“1 were more likely to carry an additional large CNV agrees with a ‘‘two-hit model’’ for developmental disorders [17].”
The genetics of autistic disorders and its clinical relevance: a review of the literature
Freitag, C. M. (2007) · Molecular Psychiatry · doi:10.1038/sj.mp.4001896 · Cited by 638 · cited 1×
“Previously, twin and family studies have conclusively described ASD as the most ‘‘genetic’’ of neuropsychiatric disorders, with concordance rates of 82–92% in monozygotic twins versus 1–10% in dizygotic twins [3], but a recent study finds evidence for a more substantial environmental component [4].”
Self-citationBourgeron, T. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.06.003 · Cited by 637 · cited 2×
“NRXN1, NLGN3/4X and SHANK2/3 has demonstrated that a synaptic defect might be at the origin of ASD [5,6].”
Self-citationColella, S., Yau, C., Taylor, J. M., Mirza, G., Butler, H., Clouston, P., Bassett, A. S., Seller, A., Holmes, C. C., & Ragoussis, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm076 · Cited by 616 · cited 3×
“When the QC criteria were met, we used two CNV calling algorithms, QuantiSNP [86] and PennCNV [87], and the CNV viewer, SnipPeep (http://snippeep.”
The Autistic Neuron: Troubled Translation?
Kelleher, R. J., & Bear, M. F. (2008) · Cell · doi:10.1016/j.cell.2008.10.017 · Cited by 598 · cited 1×
“, one of the major biological mechanisms associated with ASD”
A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures.
Sharp, A. J., Mefford, H. C., Li, K., Baker, C., Skinner, C., Stevenson, R. E., Schroer, R. J., Novara, F., De Gregori, M., Ciccone, R., et al. (2008) · Nature Genetics · doi:10.1038/ng.93 · Cited by 582 · cited 1×
“Notably, the three ASD patients with de novo SHANK2 deletions also carried CNVs on chromosome 15q11– q13, a region associated with ASD [43,47,48,50–52, 72 ].”
The Shank family of scaffold proteins
Sheng, M., & Kim, E. (2000) · Journal of Cell Science · doi:10.1242/jcs.113.11.1851 · Cited by 578
Searching for ways out of the autism maze: genetic, epigenetic and environmental clues
Persico, A. M., & Bourgeron, T. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.05.010 · Cited by 575 · cited 1×
“The difference in clinical outcome of mutation carriers has been attributed to the presence of still uncharacterized additional genetic, epigenetic and/or environmental factors [27].”
Self-citationMutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation
Berkel, S., Marshall, C. R., Weiss, B., Howe, J., Roeth, R., Moog, U., Endris, V., Roberts, W., Szatmari, P., Pinto, D., et al. (2010) · Nature Genetics · doi:10.1038/ng.589 · Cited by 563 · cited 13×
“Mutations of ProSAP1/SHANK2 have also recently been reported in both, ASD and ID [9,26].”
InfluentialSelf-citation15q13.3 microdeletions increase risk of idiopathic generalized epilepsy.
Helbig, I., Mefford, H. C., Sharp, A. J., Guipponi, M., Fichera, M., Franke, A., Muhle, H., de Kovel, C., Baker, C., von Spiczak, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.292 · Cited by 551 · cited 1×
“51%) [50], and in subjects referred for chromosomal microarray analysis (55 of 8832, 0.”
Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies
de Kovel, C. G. F., Trucks, H., Helbig, I., Mefford, H. C., Baker, C., Leu, C., Kluck, C., Muhle, H., von Spiczak, S., Ostertag, P., et al. (2010) · Brain · doi:10.1093/brain/awp262 · Cited by 445
Schalling, D., Åsberg, M., Edman, G., & Oreland, L. (1987) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1987.tb02881.x · Cited by 441 · cited 4×
“In addition, she was ascertained for axis I psychiatric disorders and personality traits using the Temperament and Character Inventory (TCI) [38] and the Karolinska Scales of Personality (KSP) [39].”
InfluentialMiller, D. T., Shen, Y., Weiss, L. A., Korn, J., Anselm, I., Bridgemohan, C., Cox, G. F., Dickinson, H., Gentile, J., Harris, D. J., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.059907 · Cited by 427 · cited 1×
“CHRNA7 and CYFIP1 were already proposed as susceptibility genes for neuropsychiatric disorders [43,45,49,51], and our study provides additional support for this association.”
Clinical Genetic Testing for Patients With Autism Spectrum Disorders
Shen, Y., Dies, K. A., Holm, I. A., Bridgemohan, C., Sobeih, M. M., Caronna, E. B., Miller, K. J., Frazier, J. A., Silverstein, I., Picker, J., et al. (2010) · Pediatrics · doi:10.1542/peds.2009-1684 · Cited by 394 · cited 1×
“3 deletions ( , 1.5 Mb) between BP4 and BP5, encompassing the CHRNA7 locus have been associated with disorders such as ID, epilepsy, schizophrenia, and ASD [43,46–48, 50,52– 54, 57– 59 ].”
InfluentialSupport for the involvement of large copy number variants in the pathogenesis of schizophrenia.
Kirov, G., Grozeva, D., Norton, N., Ivanov, D., Mantripragada, K. K., Holmans, P., International Schizophrenia Consortium, the Wellcome Trust Case Control Consortium, Craddock, N., Owen, M. J., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp043 · Cited by 390 · cited 1×
“The BP1-BP2 deletion is associated with phenotypic variability and has been reported in individuals with neurodevelopmental disorders [20], schizophrenia [53,60], ASD [44–46,49], and epilepsy [61].”
Gauthier, J., Champagne, N., Lafrenière, R. G., Xiong, L., Spiegelman, D., Brustein, E., Lapointe, M., Peng, H., Côté, M., Noreau, A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906232107 · Cited by 369 · cited 1×
“Deletions of ProSAP2/SHANK3 at chromosome 22q13 are one of the major genetic abnormalities in neurodevelopmental disorders [20], and mutations of ProSAP2/ SHANK3 have been identified in patients with ASD, intellectual disability (ID) and schizophrenia [7,23–25].”
van Bon, B. W. M., Mefford, H. C., Menten, B., Koolen, D. A., Sharp, A. J., Nillesen, W. M., Innis, J. W., de Ravel, T. J. L., Mercer, C. L., Fichera, M., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063412 · Cited by 358
Hamdan, F. F., Gauthier, J., Araki, Y., Lin, D.-T., Yoshizawa, Y., Higashi, K., Park, A.-R., Spiegelman, D., Dobrzeniecka, S., Piton, A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.02.001 · Cited by 349 · cited 1×
“Deletions of ProSAP2/SHANK3 at chromosome 22q13 are one of the major genetic abnormalities in neurodevelopmental disorders [20], and mutations of ProSAP2/ SHANK3 have been identified in patients with ASD, intellectual disability (ID) and schizophrenia [7,23–25].”
Boeckers, T. M., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00931.x · Cited by 349 · cited 1×
“Both SNTG2 and SHANK2 are scaffolding proteins localized in actin rich structures [81–83] and bind directly to neuroligins [66].”
Self-citationKey role for gene dosage and synaptic homeostasis in autism spectrum disorders
Toro, R., Konyukh, M., Delorme, R., Leblond, C., Chaste, P., Fauchereau, F., Coleman, M., Leboyer, M., Gillberg, C., & Bourgeron, T. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.007 · Cited by 331 · cited 5×
“NRXN1, NLGN3/4X and SHANK2/3 has demonstrated that a synaptic defect might be at the origin of ASD [5,6].”
InfluentialSelf-citationDurand, C. M., Perroy, J., Loll, F., Perrais, D., Fagni, L., Bourgeron, T., Montcouquiol, M., & Sans, N. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.57 · Cited by 316 · cited 1×
“Recently, Berkel et al. 2011 showed that two inherited (L1008_P1009dup, T1127M) and one de novo (R462X) SHANK2 mutations identified in patients with ASD affect spine volume and reduced Shank2 cluster sizes [70].”
Self-citationSchenck, A., Bardoni, B., Langmann, C., Harden, N., Mandel, J.-L., & Giangrande, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00354-4 · Cited by 316
Novel submicroscopic chromosomal abnormalities detected in autism spectrum disorder.
Christian, S. L., Brune, C. W., Sudi, J., Kumar, R. A., Liu, S., Karamohamed, S., Badner, J. A., Matsui, S., Conroy, J., McQuaid, D., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.01.009 · Cited by 299 · cited 1×
“[20,63,64] and schizophrenia [65], respectively.”
Characterization of the Shank Family of Synaptic Proteins
Lim, S., Naisbitt, S., Yoon, J., Hwang, J.-I., Suh, P.-G., Sheng, M., & Kim, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29510 · Cited by 295 · cited 1×
“Finally, the shortest isoform (AF141901), also originally described in the rat, results in premature termination of the transcription before the SAM domain due to an alternative 39 end in exon 22 [32] (Figure 1A).”
Recurrent CNVs Disrupt Three Candidate Genes in Schizophrenia Patients
Vrijenhoek, T., Buizer-Voskamp, J. E., van der Stelt, I., Strengman, E., Sabatti, C., Geurts van Kessel, A., Brunner, H. G., Ophoff, R. A., & Veltman, J. A. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.09.011 · Cited by 265
Ben-Shachar, S., Lanpher, B., German, J. R., Qasaymeh, M., Potocki, L., Nagamani, S. C. S., Franco, L. M., Malphrus, A., Bottenfield, G. W., Spence, J. E., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.064378 · Cited by 261 · cited 2×
“Notably, the three ASD patients with de novo SHANK2 deletions also carried CNVs on chromosome 15q11– q13, a region associated with ASD [43,47,48,50–52, 72 ].”
InfluentialBoeckers, T. M., Kreutz, M. R., Winter, C., Zuschratter, W., Smalla, K.-H., Sanmarti-Vila, L., Wex, H., Langnaese, K., Bockmann, J., Garner, C. C., et al. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-15-06506.1999 · Cited by 257 · cited 2×
“In situ hybridization was performed essentially as described previously [28].”
BackgroundMethodSelf-citationCytogenetic abnormalities and fragile-x syndrome in Autism Spectrum Disorder
Reddy, K. S. (2005) · BMC Medical Genetics · doi:10.1186/1471-2350-6-3 · Cited by 222 · cited 1×
“It was supported by the identification of apparently monogenic forms of ASD, each affecting a limited number of patients (1–2% for the most replicated genes) [7–14].”
Boeckers, T. M., Winter, C., Smalla, K.-H., Kreutz, M. R., Bockmann, J., Seidenbecher, C., Garner, C. C., & Gundelfinger, E. D. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1489 · Cited by 200 · cited 1×
“Two additional isoforms, ProSAP1A (AB208026) and ProSAP1 (AB208027), originating from distinct promoters, were previously detected in the rat [30,31].”
Self-citationHogart, A., Leung, K. N., Wang, N. J., Wu, D. J., Driscoll, J., Vallero, R. O., Schanen, N. C., & LaSalle, J. M. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.061580 · Cited by 199 · cited 1×
“Interestingly, it was also found that, in contrast to the gene copy number, the transcript levels CHRNA7 were reduced in neuronal cells [74] or brain samples with maternal 15q duplication [75].”
Determination of absolute protein numbers in single synapses by a GFP-based calibration technique
Sugiyama, Y., Kawabata, I., Sobue, K., & Okabe, S. (2005) · Nature Methods · doi:10.1038/nmeth783 · Cited by 189 · cited 1×
“Both SNTG2 and SHANK2 are scaffolding proteins localized in actin rich structures [81–83] and bind directly to neuroligins [66].”
Shinawi, M., Schaaf, C. P., Bhatt, S. S., Xia, Z., Patel, A., Cheung, S. W., Lanpher, B., Nagl, S., Herding, H. S., Nevinny-Stickel, C., et al. (2009) · Nature Genetics · doi:10.1038/ng.481 · Cited by 183 · cited 1×
“3 deletions ( , 1.5 Mb) between BP4 and BP5, encompassing the CHRNA7 locus have been associated with disorders such as ID, epilepsy, schizophrenia, and ASD [43,46–48, 50,52– 54, 57– 59 ].”
InfluentialDepienne, C., Moreno‐De‐Luca, D., Héron, D., Bouteiller, D., Gennetier, A., Delorme, R., Chaste, P., Siffroi, J., Chantot‐Bastaraud, S., Benyahia, B., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.01.025 · Cited by 182 · cited 3×
“The bottom part of the figure indicates the location of the deletions/duplications previously associated with neuropsychiatric disorders [43–61].”
Self-citationOligogenic heterozygosity in individuals with high-functioning autism spectrum disorders
Schaaf, C. P., Sabo, A., Sakai, Y., Crosby, J., Muzny, D., Hawes, A., Lewis, L., Akbar, H., Varghese, R., Boerwinkle, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr243 · Cited by 175 · cited 1×
“However, the occurrence of two or more deleterious copy number variants (CNV) or mutations in a subset of patients also suggested that independent loci could act in concert to induce the development of ASD [9,13–16].”
A 15q13.3 microdeletion segregating with autism
and the International Molecular Genetic Study of Autism Consortium (IMGSAC), Pagnamenta, A. T., Wing, K., Sadighi Akha, E., Knight, S. J., Bölte, S., Schmötzer, G., Duketis, E., Poustka, F., Klauck, S. M., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.228 · Cited by 174 · cited 1×
“3 deletions ( , 1.5 Mb) between BP4 and BP5, encompassing the CHRNA7 locus have been associated with disorders such as ID, epilepsy, schizophrenia, and ASD [43,46–48, 50,52– 54, 57– 59 ].”
InfluentialSelf-citationRosenfeld, J. A., Ballif, B. C., Torchia, B. S., Sahoo, T., Ravnan, J. B., Schultz, R., Lamb, A., Bejjani, B. A., & Shaffer, L. G. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181f0c5f3 · Cited by 169 · cited 1×
“[20,63,64] and schizophrenia [65], respectively.”
Doornbos, M., Sikkema-Raddatz, B., Ruijvenkamp, C. A. L., Dijkhuizen, T., Bijlsma, E. K., Gijsbers, A. C. J., Hilhorst-Hofstee, Y., Hordijk, R., Verbruggen, K. T., Kerstjens-Frederikse, W. S. (., et al. (2009) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2009.03.010 · Cited by 165 · cited 1×
“CHRNA7 and CYFIP1 were already proposed as susceptibility genes for neuropsychiatric disorders [43,45,49,51], and our study provides additional support for this association.”
Berkel, S., Tang, W., Treviño, M., Vogt, M., Obenhaus, H. A., Gass, P., Scherer, S. W., Sprengel, R., Schratt, G., & Rappold, G. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/ddr470 · Cited by 162 · cited 3×
“Recently, Berkel et al. 2011 showed that two inherited (L1008_P1009dup, T1127M) and one de novo (R462X) SHANK2 mutations identified in patients with ASD affect spine volume and reduced Shank2 cluster sizes [70].”
Self-citationDelineation of 15q13.3 microdeletions.
Masurel‐Paulet, A., Andrieux, J., Callier, P., Cuisset, J., Le Caignec, C., Holder, M., Thauvin‐Robinet, C., Doray, B., Flori, E., Alex‐Cordier, M., et al. (2010) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01374.x · Cited by 145 · cited 2×
“Notably, the three ASD patients with de novo SHANK2 deletions also carried CNVs on chromosome 15q11– q13, a region associated with ASD [43,47,48,50–52, 72 ].”
InfluentialConfirmed rare copy number variants implicate novel genes in schizophrenia
Tam, G. W. C., van de Lagemaat, L. N., Redon, R., Strathdee, K. E., Croning, M. D. R., Malloy, M. P., Muir, W. J., Pickard, B. S., Deary, I. J., Blackwood, D. H. R., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380445 · Cited by 139 · cited 2×
“The bottom part of the figure indicates the location of the deletions/duplications previously associated with neuropsychiatric disorders [43–61].”
Poot, M., Beyer, V., Schwaab, I., Damatova, N., van’t Slot, R., Prothero, J., Holder, S. E., & Haaf, T. (2010) · neurogenetics · doi:10.1007/s10048-009-0205-1 · Cited by 137 · cited 1×
“However, the occurrence of two or more deleterious copy number variants (CNV) or mutations in a subset of patients also suggested that independent loci could act in concert to induce the development of ASD [9,13–16].”
Self-citationSzafranski, P., Schaaf, C. P., Person, R. E., Gibson, I. B., Xia, Z., Mahadevan, S., Wiszniewska, J., Bacino, C. A., Lalani, S., Potocki, L., et al. (2010) · Human Mutation · doi:10.1002/humu.21284 · Cited by 134 · cited 7×
“ABCC6, ATP-binding cassette, sub-family C, member 6 pseudogene 2; ADAM, ADAM metallopeptidase; AMY1, amylase (salivary); AMY2A, amylase (pancreatic); ARHGAP11B, Rho GTPase activating protein 11B; CAMSAP1L1, calmodulin regulated spectrin-associated protein 1-like 1; CHRNA7, cholinergic receptor, nicotinic, alpha 7; CNT…”
InfluentialAutism spectrum disorder diagnoses in Stockholm preschoolers
Fernell, E., & Gillberg, C. (2010) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2010.01.007 · Cited by 129 · cited 1×
“The prevalence of ASD is about 1/100, but closer to 1/300 for typical autism [2].”
Self-citationBoeckers, T. M., Liedtke, T., Spilker, C., Dresbach, T., Bockmann, J., Kreutz, M. R., & Gundelfinger, E. D. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02910.x · Cited by 113 · cited 1×
“. We have tested all the variants (n = 16) identified in our first screen of 230 patients with ASD and 230 controls: 5 were detected only in patients (V717F, A729T, G1170R, D1535N and L1722P), 6 were detected in patients and controls (S557N, R569H, K780Q, R818H, Y967C and P1586L) and 5 were only found in controls (L62…”
Self-citationvan der Zwaag, B., Staal, W. G., Hochstenbach, R., Poot, M., Spierenburg, H. A., de Jonge, M. V., Verbeek, N. E., van 't Slot, R., van Es, M. A., Staal, F. J., et al. (2010) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31055 · Cited by 108
Self-citationYasui, D. H., Scoles, H. A., Horike, S.-I., Meguro-Horike, M., Dunaway, K. W., Schroeder, D. I., & LaSalle, J. M. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr357 · Cited by 102 · cited 1×
“The role of CHRNA7 in ASD was recently supported by the observation of low levels of CHRNA7 mRNA in the post-mortem brain from patients with ASD [73].”
Melke, J., Westberg, L., Nilsson, S., Landén, M., Soderstrom, H., Baghaei, F., Rosmond, R., Holm, G., Björntorp, P., Nilsson, L.-G., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.10.1017 · Cited by 89 · cited 1×
“for the extraversion factor, and for one of its subscales, monotony avoidance [40].”
Self-citationDendritic signalling and homeostatic adaptation
Yu, L. M. Y., & Goda, Y. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.07.002 · Cited by 83 · cited 1×
“These proteins play a crucial role in the formation and stabilization of synapses [21], as well as in synaptic homeostasis [22].”
Psychiatric III‐Health of Women and Its Relationship to Obesity and Body Fat Distribution
Rosmond, R., & Björntorp, P. A. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00361.x · Cited by 81 · cited 2×
“This control female was part of a previous epidemiological study [37] and had been extensively examined for anthropometrics and cardiovascuAuthor Summary”
Murthy, S. K., Nygren, A. O. H., El Shakankiry, H. M., Schouten, J. P., Al Khayat, A. I., Ridha, A., & Al Ali, M. T. (2007) · Cytogenetic and Genome Research · doi:10.1159/000097433 · Cited by 79 · cited 2×
“The bottom part of the figure indicates the location of the deletions/duplications previously associated with neuropsychiatric disorders [43–61].”
Contactin 4 as an autism susceptibility locus
Cottrell, C. E., Bir, N., Varga, E., Alvarez, C. E., Bouyain, S., Zernzach, R. C., Thrush, D. L., Evans, J., Trimarchi, M. P., Butter, E. M., et al. (2011) · Autism Research · doi:10.1002/aur.184 · Cited by 69 · cited 1×
“3 associated with ASD [62], as well as a paternally inherited deletion within the protocadherin PCDHA1-10 gene cluster on chromosome 5q31.”
Characterization of an ankyrin repeat-containing Shank2 isoform (Shank2E) in liver epithelial cells
McWILLIAMS, R. R., GIDEY, E., FOUASSIER, L., WEED, S. A., & DOCTOR, R. B. (2004) · Biochemical Journal · doi:10.1042/bj20031577 · Cited by 63 · cited 1×
“Two additional isoforms, ProSAP1A (AB208026) and ProSAP1 (AB208027), originating from distinct promoters, were previously detected in the rat [30,31].”
γ-Syntrophin scaffolding is spatially and functionally distinct from that of the α/β syntrophins
Alessi, A., Bragg, A. D., Percival, J. M., Yoo, J., Albrecht, D. E., Froehner, S. C., & Adams, M. E. (2006) · Experimental Cell Research · doi:10.1016/j.yexcr.2006.06.019 · Cited by 60
Meguro-Horike, M., Yasui, D. H., Powell, W., Schroeder, D. I., Oshimura, M., LaSalle, J. M., & Horike, S.-I. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr298 · Cited by 59 · cited 1×
“Interestingly, it was also found that, in contrast to the gene copy number, the transcript levels CHRNA7 were reduced in neuronal cells [74] or brain samples with maternal 15q duplication [75].”
Durand, C. M., Kappeler, C., Betancur, C., Delorme, R., Quach, H., Goubran‐Botros, H., Melke, J., Nygren, G., Chabane, N., Bellivier, F., et al. (2006) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30229 · Cited by 55 · cited 6×
“ABCC6, ATP-binding cassette, sub-family C, member 6 pseudogene 2; ADAM, ADAM metallopeptidase; AMY1, amylase (salivary); AMY2A, amylase (pancreatic); ARHGAP11B, Rho GTPase activating protein 11B; CAMSAP1L1, calmodulin regulated spectrin-associated protein 1-like 1; CHRNA7, cholinergic receptor, nicotinic, alpha 7; CNT…”
InfluentialSelf-citationBrandstätter, J. H., Dick, O., & Boeckers, T. M. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.20194 · Cited by 45 · cited 1×
“This domain binds to GRIP and b-PIX, two proteins linking SHANK to glutamate AMPA receptors and actin skeleton, respectively [36].”
Self-citationWischmeijer, A., Magini, P., Giorda, R., Gnoli, M., Ciccone, R., Cecconi, I., Franzoni, E., Mazzanti, L., Romeo, G., Zuffardi, O., et al. (2010) · Molecular Syndromology · doi:10.1159/000322054 · Cited by 40 · cited 1×
“with speech and developmental delay [35].”
Presynaptic Targeting of α4β2 Nicotinic Acetylcholine Receptors Is Regulated by Neurexin-1β
Cheng, S.-B., Amici, S. A., Ren, X.-Q., McKay, S. B., Treuil, M. W., Lindstrom, J. M., Rao, J., & Anand, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.017384 · Cited by 37
Activity‐driven mobilization of post‐synaptic proteins
Gutiérrez, R. C., Flynn, R. E., Hung, J., Kertesz, A. C., Sullivan, A., Zamponi, G. W., El-Husseini, A., & Colicos, M. A. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07007.x · Cited by 27 · cited 1×
“and might be the consequence of polymorphisms located in specific regulatory sequences and/or activity dependent expression of this family of post-synaptic proteins”
Yamakawa, H., Oyama, S., Mitsuhashi, H., Sasagawa, N., Uchino, S., Kohsaka, S., & Ishiura, S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.127 · Cited by 27 · cited 3×
“Both SNTG2 and SHANK2 are scaffolding proteins localized in actin rich structures [81–83] and bind directly to neuroligins [66].”
Postsynaptic scaffolds for nicotinic receptors on neurons
Neff, R. A., Gómez‐Varela, D., Fernandes, C., & Berg, D. K. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.52 · Cited by 26 · cited 1×
“Finally, functional studies have shown that NLGN and NRXN, which belong to the same synaptic pathway, are key organizers of the clustering of nicotinic receptors at the synapse [76–78].”
Multiple cell adhesion molecules shaping a complex nicotinic synapse on neurons
Triana‐Baltzer, G., Liu, Z., Gounko, N. V., & Berg, D. K. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.05.017 · Cited by 16 · cited 1×
“Finally, functional studies have shown that NLGN and NRXN, which belong to the same synaptic pathway, are key organizers of the clustering of nicotinic receptors at the synapse [76–78].”
Syntrophin-2 is required for eye development in Drosophila
Nagai, R., Hashimoto, R., Tanaka, Y., Taguchi, O., Sato, M., Matsukage, A., & Yamaguchi, M. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.10.009 · Cited by 7 · cited 1×
“Both SNTG2 and SHANK2 are scaffolding proteins localized in actin rich structures [81–83] and bind directly to neuroligins [66].”
Research works printed but not linked: 1
- The international schizophrenia consortium 2008 Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455 237 241 18668038 PMC3912847 · DOI · Paper page
Cited by
From the genetic architecture to synaptic plasticity in autism spectrum disorder
Bourgeron, T. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3992 · Cited by 975
Self-citationThe Cerebellum, Sensitive Periods, and Autism
Wang, S. S.-H., Kloth, A. D., & Badura, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.07.016 · Cited by 838
“In most cases, each allele is a variant of an essential gene, and its presence most often leads to normal-range function (Leblond et al., 2012; O’Roak et al., 2011).”
BackgroundWhole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder
C Yuen, R. K., Merico, D., Bookman, M., L Howe, J., Thiruvahindrapuram, B., Patel, R. V., Whitney, J., Deflaux, N., Bingham, J., Wang, Z., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4524 · Cited by 844
“Risk variants that remain undiscovered to this point are expected to be individually rare 9,18,22 , possibly involved in complex combinations 18,25 and include single nucleotide variants (SNVs), small insertions and deletions (indels), more complex CNVs 14,18,20 and other structural alterations…”
Self-citationAutism risk factors: genes, environment, and gene-environment interactions
Chaste, P., & Leboyer, M. (2012) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2012.14.3/pchaste · Cited by 807
“Several studies recently supported the existence of such a combination of rare variants in some cases.(39,49,50) Another hypothesis is the contribution of both rare and frequent variants.”
BackgroundSelf-citationAutistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function
Won, H., Lee, H.-R., Gee, H. Y., Mah, W., Kim, J.-I., Lee, J., Ha, S., Chung, C., Jung, E. S., Cho, Y. S., et al. (2012) · Nature · doi:10.1038/nature11208 · Cited by 695
Metadata
- Authors
- Leblond, C. S., Heinrich, J., Delorme, R., Proepper, C., Betancur, C., Huguet, G., Konyukh, M., Chaste, P., Ey, E., Rastam, M., Anckarsäter, H., Nygren, G., Gillberg, I. C., Melke, J., Toro, R., Regnault, B., Fauchereau, F., Mercati, O., Lemière, N., Skuse, D., Poot, M., Holt, R., Monaco, A. P., Järvelä, I., Kantojärvi, K., Vanhala, R., Curran, S., Collier, D. A., Bolton, P., Chiocchetti, A., Klauck, S. M., Poustka, F., Freitag, C. M., Waltes, R., Kopp, M., Duketis, E., Bacchelli, E., Minopoli, F., Ruta, L., Battaglia, A., Mazzone, L., Maestrini, E., Sequeira, A. F., Oliveira, B., Vicente, A., Oliveira, G., Pinto, D., Scherer, S. W., Zelenika, D., Delepine, M., Lathrop, M., Bonneau, D., Guinchat, V., Devillard, F., Assouline, B., Mouren, M.-C., Leboyer, M., Gillberg, C., Boeckers, T. M., & Bourgeron, T.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Universität Ulm (DE)
- Lund University (SE)
- University of Gothenburg (SE)
- University College London (GB)
- University Medical Center Utrecht (NL)
- Centre for Human Genetics (GB)
- University of Helsinki (FI)
- King's College London (GB)
- German Cancer Research Center (DE)
- Goethe University Frankfurt (DE)
- University of Bologna (IT)
- University of Catania (IT)
- University of Lisbon (PT)
- University of Coimbra (PT)
- Hospital for Sick Children (CA)
- Hôpital Couple Enfant (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Inserm (FR)
- Corresponding author
- Bourgeron, Thomas
- ORCID
- Leblond, Claire S.
- Delorme, Richard
- Betancur, Catalina
- Huguet, Guillaume
- Konyukh, Marina
- Chaste, Pauline
- Ey, Elodie
- Nygren, Gudrun
- Melke, Jonas
- Toro, Roberto
- Skuse, David
- Poot, Martin
- Monaco, Anthony P.
- Järvelä, Irma
- Kantojärvi, Katri
- Vanhala, Raija
- Curran, Sarah
- Collier, David A.
- Bolton, Patrick
- Chiocchetti, Andreas
- Freitag, Christine M.
- Waltes, Regina
- Bacchelli, Elena
- Ruta, Liliana
- Battaglia, Agatino
- Mazzone, Luigi
- Maestrini, Elena
- Sequeira, Ana F.
- Vicente, Astrid
- Oliveira, Guiomar
- Pinto, Dalila
- Scherer, Stephen W.
- Lathrop, Mark
- Bonneau, Dominique
- Guinchat, Vincent
- Leboyer, Marion
- Gillberg, Christopher
- Boeckers, Tobias M.
- Bourgeron, Thomas
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-02-09
- Volume
- 8
- Issue
- 2
- Pages
- e1002521
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- PMC
- PMC3276563
- OpenAlex
- W2123194540
- Semantic Scholar
- a654d30603c2e12b9d4b7339f3fb4721cc260885
- Cited by
- 429
- References
- 91
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 31 · 2023: 16 · 2022: 19 · 2021: 28 · 2020: 25 · 2019: 16 · 2018: 28 · 2017: 32 · 2016: 30 · 2015: 52 · 2014: 54 · 2013: 56 · 2012: 24
- FWCI
- 35.74
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Genetics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, other-oa)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by)
- Figshare (submittedVersion, cc-by)
- Työväentutkimus Vuosikirja (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- Funders
- GlaxoSmithKline
- Wellcome Trust (075491, 075491/Z/04,, 090532)
- Fondation Orange
- National Institute for Health and Care Research (NF-SI-0510-10268)
- Deutsche Forschungsgemeinschaft
- Agence Nationale de la Recherche (ANR-08-MNPS-0037)
- Institut National de la Santé et de la Recherche Médicale
- University of Toronto
- Hospital for Sick Children
- Hersenstichting
- Assistance publique-Hôpitaux de Paris
- Canadian Institutes of Health Research (213997)
- NIH Clinical Center
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
- Keywords
- autism spectrum disorder, Shank2, de novo deletion, multiple-hit model, synaptic dysfunction, synaptic density, copy number variation, 15q11-q13, genetic modifiers, rare variants, conserved residues, neurodevelopmental disorders
- MeSH terms
- Adult, Cell Line, Child, Child Development Disorders, Pervasive, Child, Preschool, Female, Gene Expression Regulation, Humans, Male, Nerve Tissue Proteins, Neurons, Receptors, Nicotinic, Synapses, Tissue Distribution, Sequence Deletion, Alternative Splicing, Gene Dosage, Protein Isoforms, RNA Splice Sites, Adaptor Proteins, Signal Transducing, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.